Matches 1 - 50 out of 56 1 2 >


Match Document Document Title
DE112017001620T5 System for chemiluminescence-based detection of methicillin-resistant Staphylococcus aureus  
The present invention includes an apparatus and related method for determining the presence or absence of methicillin-resistant Staphylococcus aureus in a sample. The disclosure includes the...
DE102011121238A1 SINGLE DOMAIN ANTIBODIES Clostridium difficile TOXINS  
The invention relates to antigen-binding polypeptides comprising the CDR1, CDR2, and CDR3 region of a VHH domain of a camelid-Heavy chain antibody. The polypeptides bind specifically in the field...
DE102011006781A1 Antibody product comprising n specific antibodies  
Antibody product comprising n specific antibodies characterized in that a) have the n specific antibody based in each case an antibody level of at least 6 / n wt .-% of the total antibody portion...
DE102010018085A1 A method for detection of a Salmonella infection  
The invention relates to a diagnostic method for the detection of salmonella infection or salmonella contamination. Areas of application are medicine, veterinary medicine and various branches of...
DE102008029688A1 Determining and identifying variant of Clostridium difficile strain in sample, comprises obtaining sample, contacting sample with antibody, detecting antibody reaction, comparing obtained reaction pattern with reference and correlating  
Determining and identifying a variant of Clostridium difficilestrain in a sample, comprises: (a) obtaining a body exudate sample and/or body tissue sample; (b) contacting the sample with at least...
DE102008029688B4 A method for the detection and identification of a variant strain of C. difficile in a sample  
In vitro method for the detection and identification of a virulent, LCTs producing, C. difficile variant strain in a sample, characterized by the following process steps: (a) contacting a...
DE102006053385B4 Enterococcus faecalis antigen  
Enterococcus faecalis strain type 5 antigen, at least one disaccharide unit comprising, having the following formula: where R1 OH, X = O, Y = O and CA lactyl is.
DE102006053385A1 Enterococcus faecalis and / or Enterococcus faecium antigen  
The This invention relates generally to the field of detection and prevention of infectious diseases caused by Enterococcus faecalis and / or Enterococcus faecium caused. In particular relates to...
DE102007024383A1 Ddeodorant or antiperspirant composition comprises an antibody that is directed against a defined microorganism and is isolated from egg yolk  
Cosmetic or dermatological deodorant or antiperspirant composition comprises an antibody that is directed against Streptococcus hominis, Peptostreptococcus or Micrococcus lutens and is isolated...
DE102007024381A1 Topical composition for treating acne, pimples, bad skin or seborrhea comprises an antibody that is directed against a defined microorganism and is isolated from egg yolk  
Topical composition for treating acne, pimples, bad skin or seborrhea comprises an antibody that is directed against Propionibacterium acnes, Candida albicans, Corynebacterium, Peptostreptococcus...
DE20023799U1 Detecting infections by acid-resistant microorganisms, particularly for diagnosing Helicobacter pylori, comprises immunochromatographic detection of antigen in feces  
Detecting infection by an acid-resistant microorganism (A), in a mammal, comprises using immunochromatography. Detecting infection by an acid-resistant microorganism (A), in a mammal, comprises...
DE102004010928B4 Protein for binding of prokaryotic DNA and process for the separation and enrichment of prokaryotic DNA  
A method for separating and / or enriching prokaryotic DNA comprising the steps of: a) contacting a is in solution undergoing prokaryotic DNA with a specific prokaryotic DNA-binding protein that...
DE102004010928A1 Enriching prokaryotic DNA from solution, useful e.g. for early diagnosis of bacterial infection, by treatment with protein that binds selectively to non-methylated CpG motifs then separating the complex formed  
Separation and/or enrichment of prokaryotic DNA comprising treating a solution with a specific binding protein (I) that has 25-35% homology with wild-type CGBP (CpG-binding protein), then...
DE10335131A1 Porous carbon moldings, e.g. for catalyst support; insulant, tube membrane, ex or in vivo cell culture substrate or scaffold or implant, are made by molding carbonizable polymer and removing filler or partial oxidation to form pores  
Porous carbon (C)-based molding (A) produced by mixing organic polymer material (I) carbonizable to C with non-polymeric filler (II); making semifinished molding from the mixture; carbonizing the...
DE4120345C5 Protein fragments from the central region of the flagellin of Borrelia burgdorferi, as antigens suitable for the specific detection of antibodies as well as methods for their preparation  
Protein fragment from the middle region (amino acid 132 to amino acid 266) of flagellin of Borrelia burgdorferi, characterized in that it consists of the amino acid sequence consists.
DE202004006867U1 Carbon-based moldings suitable for use as Zellkulturtr√§ger- and rearing systems  
The porous carbon-based molded body, obtainable by a process comprising the steps of: - Mixing carbonizable carbon to organic polymer materials with non-polymeric fillers; - Producing a...
DE10149715A1 Esterase EstA from Rhodococcus ruber  
The invention relates to an esterase extracted from Rhodococcus ruber, to proteins homologous thereto, to nucleic acids that code for these proteins, to antibodies directed against these proteins,...
DE10149715B4 Esterase from Rhodococcus ruber EstA  
Polynucleotide selected from the group consisting of: Polynucleotide having a nucleic acid sequence according to SEQ ID No. 1 or according to SEQ ID No. . 3
DE10149714A1 Esterase EstA from Rhodococcus sp.  
The invention concerns an esterase of Rhodococcus sp., proteins homologous with said esterase, nucleic acids coding for said proteins, antibodies directed against said proteins, as well as the...
DE10126367A1 Pharmaceutical composition comprises Borrelia antigens and encoding nucleic acid, useful for diagnosis, treatment and prevention of Lyme borreliosis  
Pharmaceutical composition comprising at least one of: (a) a polypeptide (I) comprising fully defined sequences of 251, 212, 217 or 219 amino acids as given in the specification or the...
DE10033939A1 Composition containing egg yolk antibodies and optionally microalgae extracts and oxytetracycline, useful for treatment of inflammatory conditions, especially wounds  
A composition contains egg yolk IgY (mono- or polyvalent) from SPF hens. The composition can also contain microalgae extracts and optionally oxytetracycline. Other ingredients which can be present...
DE19935508A1 Producing a glycoprotein product that stimulates tumor necrosis factor alpha production, useful for treating cancer and viral infections, comprises culturing Rhodococcus fascians  
Producing a glycoprotein product (I) that stimulates tumor necrosis factor alpha (TNF- alpha ) production, comprising culturing Rhodococcus fascians (DSM 12916) in a medium containing a sugar or...
DE19925739A1 Agent with a botulinum neurotoxin  
The invention relates to a therapeutic agent with a botulinum neurotoxin.
DE19924965A1 Preparing an agent for diagnosis or control of microbial infection, useful particularly against Helicobacter, based on identification of essential genes in defective mutants  
Preparation of an agent (A) for detection, prevention and/or treatment of microbial infection by: (i) identifying essential genes (I) and corresponding polypeptides (II); (ii) identifying...
DE19917098A1 New immunogenic polypeptides from methicillin-resistant Staphylococcus aureus, useful for raising human antibodies for treating infections  
Immunogenic polypeptides (I), expressed by methicillin-resistant Staphylococcus aureus (MRSA) able to generate antibodies in humans with generalized MRSA infection, are designated PisaA and PisaB...
DE19910159A1 Specific IgY-egg yolk, their production and their use  
The invention relates to specific egg yolk antibodies IgY and the obtainment and use thereof for immunotherapy in animal breeding and animal production. Pullets are immunised and repeatedly...
DE19904795A1 Nucleic acid molecules for identifying particular bacteria, used to detect pathogens in foods, are specific for Bacillus cereus and B. thuringiensis  
One or more nucleic acid molecules (I) that are obtained from: (i) a group of bacteria that are to be detected, i.e. representatives of the species Bacillus cereus and B. thuringiensis, or these...
DE19900635A1 Selection of monoclonal antibodies  
The present invention relates to a method for selecting monoclonal antibodies. The method comprises the fusion of B-lymphocytes with myeloma cells to form hybridome cells that produce antibodies....
DE19847628A1 Outer membrane protein of Helicobacter pylori and DNA sequences, useful in vaccines and for production of diagnostic or therapeutic antibodies  
An outer membrane protein (I) from Helicobacter pylori, a fragment of (I) or a protein (II) with the same immunogenic characteristics, is new. Independent claims are also included for the...
DE19938394A1 Immunoadsorber for removing endotoxins from fluids uses avian endotoxin antibodies  
An immunoadsorber for the removal of endotoxin from fluids, comprises a carrier made of organic or synthetic polymers with endotoxin-specific antibodies. Independent claims are also included for...
DE19836084A1 Avian vitelline antibody against ammonifying microorganisms, especially soil bacterium W7/15, useful for quantifying ammonifying microorganisms in the soil by immunoassay  
Avian vitelline antibody against ammonifying microorganisms is new. Independent claims are also included for the following: (1) an antibody against soil bacterium W7/15; (2) a process for...
DE19740735A1 Antibodies specific for Borrelia burgdorferi 24 kD antigen OspC  
Polyclonal and monoclonal antibodies specific for the Borrelia burgdorferi 24 kD antigen OspC are new. Independent claims are also included for the following: (1) an antigen that immunoreacts with...
DE19739685A1 Monoclonal antibodies for the therapy and prophylaxis of diseases caused by Cl ostridium difficile  
The invention relates to monoclonal antibodies capable of recognizing and neutralizing epitopes from the ligand domain, the translocation domain or the catalytic domain for the enterotoxin (toxin...
DE4447677C2 New attenuated Pseudomonas aeruginosa strains  
The following are claimed: (A) an attenuated Pseudomonas aeruginosa (PA) strain which has a LD50 of \-2x10<-7> cells in mice and which is obtd. by isolating PA in a pure state according to...
DE19641466A1 Oral administration of an immunoglobulin preparation for the prevention of hemolytic uremic syndrome and preparation therefor  
The invention relates to the use of immunoglobulin preparations with high antibody content against EHEC hemolysin and optionally against surface antigens of EHEC hemolysin gene carrying bacteria...
DE3745019C2 Cross-protective human monoclonal antibody compsns.  
A compsn. useful in the prophylactic and/or therapeutic treatment of bacterial infection comprises human monoclonal antibodies (MAbs) reactive with at least 2 bacterial species of at least 2...
DE19630390A1 Proteins, especially membrane proteins of Helicobacter pylori, their preparation and use  
The present invention relates to novel proteins, in particular membrane proteins or proteins which are firmly associated with the membrane, which are derived from Helicobacter pylori (H. pylori)...
DE19535321A1 New adhesin of Helicobacter pylori  
The invention relates to an adherence gene AlpB from Helicobacter pylori and the polypeptide coded therefrom. This gene was achieved by transposon TnMax9 insertion (mutagenesis) from the...
DE19534579A1 Nucleic acid molecules encoding proteins that mediate the adhesion of Neisseria cells to human cells  
The invention relates to nucleic acid molecules which code proteins which mediate the adhesion of bacteria from the genus Neisseria to human cells. It also relates to the proteins coded by these...
DE19536166C1 A process for the detection of antibodies to Treponema pallidum (syphilis)  
The invention concerns a process and an agent for detecting antibodies against Treponema pallidum. A selection of recombinant antigens is gene-amplified and cloned and these gene-amplified and...
DE19548301C1 Inhibiting signal mols. involved in plant-microbial pathogen interaction  
Inhibition of signal mol. (A) of pathogens in plant-microbe interactions uses binding or catalytic antibodies (Ab) or Ab-like proteins. Also claimed is pathogen-resistant transgenic plant contg....
DE19526546A1 Prodn. of recombinant antibodies  
Prodn. of recombinant antibodies comprises: (a) selection of B cells from a lymphocyte fraction; (b) isolation of mRNA from individual B cells; (c) reverse transcription of the mRNA into cDNA; (d)...
DE19521314A1 Adh√§renzgen from Helicobacter pylori and it encoded polypeptide  
The present invention concerns an adherence gene from Helicobacter pylori, a polypeptide coded thereby and antibodies which are effective against the polypeptide.
DE4425115A1 A method for modifying the stability of antibodies  
The invention concerns a process for preparing a functional derivative or fragment of immunoglobulin or a functional immunoglobulin having improved stability in a eukaryotic or prokaryotic...
DE4419294A1 Legionella pneumophila DNA coding for major outer membrane protein  
The following are claimed: (a) a nucleic acid sequence which is a defined sequence of 907 bp given in the specification and represents the complete open reading frame coding for the 29 kD major...
DE4419399C1 Process for the preparation of heterologous bispecific antibodies  
The invention pertains to a method for producing heterologous bispecific antibodies. The object of the invention is a method designed to yield heterologous bispecific antibodies with a high level...
DE4324859A1 Oral compsn. for treating periodontal disease - contg. antibody obtd. by immunising animal with surface polysaccharide from pathogenic bacteria  
Oral compsn. contains an antibody (AB) obtd. by immunising an animal with an antigen (AG) including at least one polysaccharide (I) from the surface layer of bacteria associated with periodontal...
DE4318450A1 New primers for PCR detection of Listeria - including individual species, also new peptide(s) for raising antibodies for immunochemical detection  
New primers from the iap (invasion-associated protein) gene for amplification of nucleic acid are of formulae (Va)-(Vh) and/or their complementary sequences. X1AATATGAAAAAAGCX2 (Va)...
DE4238806A1 Methicillin-resistant staphylococcus aureus (MRSA)detection method - by detection of MRSA penicillin binding protein (PBP)2 antigen-antibody complex, and synthetic MRSA PBP2 peptides  
A detection method for methicillin-resistant Staphylococcus aureas (MRSA) or parts thereof in a sample using the disclosed peptides or derivs. thereof in immunological reactions with samples...
DE4134297A1 Monoclonal antibody specific for Mycoplasma pneumoniae  
Claimed are (i) a monoclonal antibody (Mab) and fragments thereof specific for Mycoplasma (M.) pneumoniae, pref. the P1-protein, showing less than 1% cross-reactivity with other species of M. or...

Matches 1 - 50 out of 56 1 2 >